Lexicon Pharmaceuticals, Inc. (LXRX): Price and Financial Metrics

LXRX POWR Grades

• Sentiment is the dimension where LXRX ranks best; there it ranks ahead of 81.84% of US stocks.
• LXRX's strongest trending metric is Stability; it's been moving up over the last 179 days.
• LXRX's current lowest rank is in the Momentum metric (where it is better than 4.64% of US stocks).

LXRX Stock Summary

• The ratio of debt to operating expenses for Lexicon Pharmaceuticals Inc is higher than it is for about merely 0.5% of US stocks.
• With a price/sales ratio of 1,094.34, Lexicon Pharmaceuticals Inc has a higher such ratio than 99.55% of stocks in our set.
• With a year-over-year growth in debt of -100%, Lexicon Pharmaceuticals Inc's debt growth rate surpasses only 0% of about US stocks.
• Stocks with similar financial metrics, market capitalization, and price volatility to Lexicon Pharmaceuticals Inc are VXRT, ASND, CAPR, CRDF, and TFFP.
• LXRX's SEC filings can be seen here. And to visit Lexicon Pharmaceuticals Inc's official web site, go to www.lexpharma.com.

LXRX Valuation Summary

• In comparison to the median Healthcare stock, LXRX's price/earnings ratio is 50.96% lower, now standing at 17.9.
• Over the past 243 months, LXRX's EV/EBIT ratio has gone up 27.2.
• LXRX's price/earnings ratio has moved up 32.3 over the prior 243 months.

Below are key valuation metrics over time for LXRX.

LXRX Growth Metrics

Its 5 year cash and equivalents growth rate is now at 125.24%.
• Its 4 year net cashflow from operations growth rate is now at -28.66%.
• Its year over year net income to common stockholders growth rate is now at -115.14%.

LXRX's revenue has moved down $46,920,000 over the prior 34 months.

The table below shows LXRX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	0.298	-87.017	-87.758
2021-09-30	0.483	-98.428	-67.642
2021-06-30	7.094	-121.656	38.083
2021-03-31	16.023	-146.074	-12.921
2020-12-31	23.995	-142.969	-58.574
2020-09-30	32.523	-133.101	-104.217

LXRX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• LXRX has a Quality Grade of D, ranking ahead of 14.8% of graded US stocks.
• LXRX's asset turnover comes in at 0.038 -- ranking 340th of 681 Pharmaceutical Products stocks.
• SEEL, AVEO, and OTLK are the stocks whose asset turnover ratios are most correlated with LXRX.

The table below shows LXRX's key quality metrics over time.